How to Develop and Implement a National Drug Policy - WHO Policy Perspectives on Medicines, No. 006, January 2003
(2003; 6 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentWhat is a national drug policy?
Afficher le documentObjectives of a national drug policy
Afficher le documentThe essential medicine concept is central to a national drug policy
Afficher le documentThe national drug policy process
Fermer ce répertoireKey components of a national drug policy
Afficher le documentSelection of essential medicines
Afficher le documentAffordability
Afficher le documentFinancing options
Afficher le documentSupply systems
Afficher le documentRegulation and quality assurance
Afficher le documentRational use
Afficher le documentResearch
Afficher le documentHuman resources development
Afficher le documentMonitoring and evaluation
Afficher le documentKey documents
 

Key components of a national drug policy

A national drug policy is a comprehensive framework in which each component plays an important role in achieving one or more of the general objectives of the policy (access, quality and rational use). The policy should balance the various goals and objectives, creating a complete and consistent entity. For example, access to essential medicines can only be achieved through rational selection, affordable prices, sustainable financing and reliable health and supply systems. Each of the four components of the “access frame-work” is essential but not sufficient in itself to ensure access. Similarly, rational use of medicines depends on many factors, such as rational selection, regulatory measures, educational strategies and financial incentives. Table 1 lists the key components of a national drug policy. It shows how they relate to the three main objectives of the policy and that most components cannot be linked to one objective only.

Table 1 Components of a national drug policy, linked to key policy objectives

 

Objectives:

 

Access

Quality

Rational use

Components:

     

Selection of essential medicines

X

(X)

X

Affordability

X

   

Financing options

X

   

Supply systems

X

 

(X)

Regulation and quality assurance

 

X

X

Rational use

   

X

Research

X

X

X

Human resources

X

X

X

Monitoring and evaluation

X

X

X

 

X = direct link; (X) = indirect link

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013